Send the following on WhatsApp
Continue to Chathttps://www.zonebourse.com/cours/action/REMEGEN-CO-LTD-119080101/actualite/RemeGen-Co-annonce-l-approbation-complete-de-Telitacicept-pour-le-Lupus-erythemateux-systemi-45418286/?utm_source=whatsapp&utm_medium=social&utm_campaign=share